Global Parenteral Nutrition Market is poised to be USD 17.9BN by 2025

The global Parenteral Nutrition Market was valued at $5.34 Billion in 2017 and is forecast to grow at a modest 6.6 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ x.x Billion.


Parenteral nutrition is also referred as intravenous feeding is a way to get nutrition into your body through your veins. Parenteral nutrition delivers nutrients such as sugar, carbohydrates, proteins, lipids, electrolytes, and trace elements to the body.


Parenteral nutrition can cause some serious side effects such as mouth sores, poor night vision, and skin changes. Apart from this, it can cause changes in heartbeat, confusion, convulsions or seizures, difficulty breathing, fast weight gain or weight loss, fatigue, fever or chills, increased urination, jumpy reflexes, memory loss, muscle twitching, thirst, tingling in your hands or feet, swelling of your hands, feet, or legs, weakness, or cramps, stomach pain, vomiting.


These nutrients should be removed from the refrigerator at least 6 hours before use. For the temporary purpose, physician can prescribe Peripheral Parenteral Nutrition via peripheral intravenous line, not the central line connected to superior vena cava.


There is a different type of parenteral nutrients:

  • Carbohydrates
  • Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins
  • Minerals

The key market participants include Baxter International Inc., Otsuka Pharmaceutical Factory Inc., Allergan plc, B. Braun Melsungen AG, Grifols S.A., Hospira, Sichuan Kelun Pharmaceutical Co. Ltd., Fresenius Kabi AG, Vifor Pharma, and Aculife Healthcare.


———>>> In-depth Analysis Report On Parenteral Nutrition Market by Ameri Research Inc.


Global Parenteral Nutrition Market Outlook To 2025: Key Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins, Minerals), Categories (PPN (Partial Parenteral Nutrition), TPN(Total Parenteral Nutrition)), Application (Crohn’s Disease, Cancer, Short Bowel Syndrome, Ischemic Bowel Disease, Others), Regional Segmentation, Competitive Dynamics, M&A Insights, Pricing Analysis (OPP, IPP, RAP), AndSegment Forecast



Leave a Reply

Your email address will not be published. Required fields are marked *